Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Gross Profit (2022 - 2025)

Historic Gross Profit for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$3.1 million.

  • Lucid Diagnostics' Gross Profit fell 679.61% to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year increase of 586.8%. This contributed to the annual value of -$12.1 million for FY2024, which is 1330.14% up from last year.
  • Lucid Diagnostics' Gross Profit amounted to -$3.1 million in Q3 2025, which was down 679.61% from -$2.8 million recorded in Q2 2025.
  • Lucid Diagnostics' Gross Profit's 5-year high stood at $76000.0 during Q3 2022, with a 5-year trough of -$4.9 million in Q4 2022.
  • Moreover, its 4-year median value for Gross Profit was -$3.1 million (2024), whereas its average is -$2.9 million.
  • The largest annual percentage gain for Lucid Diagnostics' Gross Profit in the last 5 years was 3127.93% (2023), contrasted with its biggest fall of 411842.11% (2023).
  • Quarter analysis of 4 years shows Lucid Diagnostics' Gross Profit stood at -$4.9 million in 2022, then soared by 31.28% to -$3.4 million in 2023, then grew by 16.66% to -$2.8 million in 2024, then decreased by 9.73% to -$3.1 million in 2025.
  • Its Gross Profit was -$3.1 million in Q3 2025, compared to -$2.8 million in Q2 2025 and -$3.2 million in Q1 2025.